Literature DB >> 2427362

Domain structure of human alpha 2-macroglobulin. Characterization of a receptor-binding domain obtained by digestion with papain.

L Sottrup-Jensen, J Gliemann, F Van Leuven.   

Abstract

Digestion of methylamine-treated alpha 2-macroglobulin (alpha 2M X MA) with catalytic amounts of papain at pH 4.5 has been investigated. Cleavage of Lys(1313)-Glu resulted in two major products, which could be separated by gel chromatography: a large disulfide bridged fragment set nearly the size of intact alpha 2M X MA, and an 18 kDa fragment, constituting the carboxy-terminal domain of alpha 2M. This domain contained the receptor recognition site, exposed as a result of cleavage of the internal beta-cysteinyl-gamma-glutamyl thiol esters in alpha 2M. Compared with alpha 2M-trypsin complex the apparent affinity for binding to rat hepatocyte receptors was 0.1 and 2% at 4 and 37 degrees C, respectively. The receptor-binding domain presumably forms a compact globular beta-barrel-type structure, stable at pH 2.5-9.0. Chemical modification experiments suggest that receptor binding is contributed by a determinant formed by the precise folding of the polypeptide chain.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2427362     DOI: 10.1016/0014-5793(86)80857-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  19 in total

1.  Structure of a rat α₁-macroglobulin receptor-binding domain dimer.

Authors:  T Xiao; D L DeCamp; S R Sprang
Journal:  Protein Sci       Date:  2000-10       Impact factor: 6.725

2.  Localization of basic residues required for receptor binding to the single alpha-helix of the receptor binding domain of human alpha2-macroglobulin.

Authors:  W Huang; K Dolmer; X Liao; P G Gettins
Journal:  Protein Sci       Date:  1998-12       Impact factor: 6.725

3.  A 16-amino acid peptide from human alpha2-macroglobulin binds transforming growth factor-beta and platelet-derived growth factor-BB.

Authors:  D J Webb; D W Roadcap; A Dhakephalkar; S L Gonias
Journal:  Protein Sci       Date:  2000-10       Impact factor: 6.725

4.  Surfactant protein D interacts with alpha2-macroglobulin and increases its innate immune potential.

Authors:  Hayley A Craig-Barnes; Barbara S Doumouras; Nades Palaniyar
Journal:  J Biol Chem       Date:  2010-03-05       Impact factor: 5.157

5.  Characterization and immunohistochemical localization of alpha 2-macroglobulin receptor (low-density lipoprotein receptor-related protein) in human brain.

Authors:  B B Wolf; M B Lopes; S R VandenBerg; S L Gonias
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

6.  Acute phase proteins are major clients for the chaperone action of α₂-macroglobulin in human plasma.

Authors:  Amy R Wyatt; Nathan W Zammit; Mark R Wilson
Journal:  Cell Stress Chaperones       Date:  2012-08-16       Impact factor: 3.667

7.  Binding of platelet-derived growth factor-BB and transforming growth factor-beta 1 to alpha 2-macroglobulin in vitro and in vivo: comparison of receptor-recognized and non-recognized alpha 2-macroglobulin conformations.

Authors:  K P Crookston; D J Webb; J Lamarre; S L Gonias
Journal:  Biochem J       Date:  1993-07-15       Impact factor: 3.857

8.  C3bi receptor (complement receptor type 3) recognizes a region of complement protein C3 containing the sequence Arg-Gly-Asp.

Authors:  S D Wright; P A Reddy; M T Jong; B W Erickson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

9.  Differences in the binding of transforming growth factor beta 1 to the acute-phase reactant and constitutively synthesized alpha-macroglobulins of rat.

Authors:  D J Webb; K P Crookston; N L Figler; J Lamarre; S L Gonias
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

10.  Molecular dissection of the human alpha2-macroglobulin subunit reveals domains with antagonistic activities in cell signaling.

Authors:  Elisabetta Mantuano; Gatambwa Mukandala; Xiaoqing Li; W Marie Campana; Steven L Gonias
Journal:  J Biol Chem       Date:  2008-05-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.